Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-18

FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Yaopharma Co., Ltd.)

View source ↗

Summary

FDA approved a supplemental application for venlafaxine hydrochloride from Yaopharma Co., Ltd., enabling the generic drug to be marketed. This is a supplemental…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine hydrochloride (Venlafaxine hydrochloride)

Snippet

SUPPL AP for VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)